January 04, 2025 04:35 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow | Punjab cop dismissed for facilitating TV interview of Larence Bishnoi while in custody | 'Not Veer Savarkar', Congress student wing demands Delhi college be named after Manmohan Singh | 'Cowardly': PM Modi condemns New Orleans terrorist attack that killed 15 | Prashant Kishor starts fast unto death over Bihar Public Service Commission prelims cancellation demand | Bangladesh court denies bail to arrested Hindu monk Chinmoy Krishna Das
Chinese vax took longer than COVAXIN to get approval, says WHO

Chinese vax took longer than COVAXIN to get approval, says WHO

Nov 04, 2021, at 06:20 am

New Delhi/IBNS: Covaxin did not take the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, according to Chief Scientist Dr Soumya Swaminathan.

Bharat Biotech's COVAXIN gets WHO approval

Bharat Biotech's COVAXIN gets WHO approval

Nov 03, 2021, at 11:42 pm

New Delhi/IBNS: The World Health Organization (WHO) has given emergency use approval to Bharat Biotech's Covaxin, sources said Wednesday, clearing the way for the 'made-in-India' vaccine to get recognised by other nations and Indians inoculated with the shot would no longer need to self-quarantine or face restrictions when going abroad.

Decision on Covaxin's emergency use listing in 4-6 weeks: WHO

Decision on Covaxin's emergency use listing in 4-6 weeks: WHO

Jul 11, 2021, at 02:11 am

New Delhi/IBNS: The World Health Organisation (WHO) will take a decision on emergency use approval for Bharat Biotech's Covaxin in the next four to six weeks, Soumya Swaminathan, the UN health body's chief scientist has said.